Profil bibliographique

Raymond Woo-Jun Jang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

144Publications signalées

6074Citations signalées

3Affiliations récentes

Institutions déclarées

University Health Network University of Toronto Princess Margaret Cancer Centre

Domaines associés

Gastric Cancer Management and OutcomesEsophageal Cancer Research and TreatmentHead and Neck Cancer StudiesNutrition and Health in AgingLung Cancer Treatments and Mutations

Publications récentes

2025 preprintOpenAlex

Integrated whole-genome and transcriptome sequencing reveals divergent evolutionary processes across biliary tract cancer subtypes

Felix E.G. Beaudry, Duhan Yendi, Danielle Arshinoff, Nicholas Light et autres

0 citationsbioRxiv (Cold Spring Harbor Laboratory)

2025 articleOpenAlex

Clinician perspectives on a novel geriatric assessment tool for older adults with cancer

M. Rezk, Sara Durbano, Cristian R. Munteanu, Bill Quach et autres

0 citationsJournal of Geriatric Oncology

Accès ouvert 2025 articleOpenAlex

Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Camilo Jiménez, Mikkel Andreassen, Alice Durand, Sophie Moog et autres

41 citationsNew England Journal of Medicine

2025 conference-abstractOpenAlex

Leveraging the power of diagnostic metrics to competency based medical education (CBME) implementation in medical oncology (MO) across Canada.

Anna Tomiak, Nazik Hammad, Heather Braund, Oluwatoyosi Kuforjii et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2025 conference-abstractOpenAlex

Adaptive organoid-based precision therapy study in pancreatic cancer (ADOPT): A phase II single-arm study to evaluate the efficacy of patient-derived organoid (PDO)-directed therapy in advanced pancreatic ductal adenocarcinoma (PDAC).

Ronan Andrew McLaughlin, Nikta Feizi, Felix E.G. Beaudry, Eugenia Flores‐Figueroa et autres

0 citationsJournal of Clinical Oncology

2025 conference-abstractOpenAlex

Abstract 5813: Evolution of the tumor immune microenvironment (TIME) in hepatocellular carcinoma (HCC) with liver metastases treated with atezolizumab-bevacizumab (INTEGRATE)

Harry Harvey, Stephanie M. Wong, Jehan Vakharia, Simone C. Stone et autres

0 citationsCancer Research

Accès ouvert 2025 articleOpenAlex

Supporting older adults with cancer and their support person through geriatric assessment and remote exercise and education: The SOAR study protocol

N. Jebanesan, Shabbir M.H. Alibhai, Daniel Santa Mina, J. Shawn Jones et autres

1 citationJournal of Geriatric Oncology

2025 conference-abstractOpenAlex

Germline pathogenic variants in a cohort of individuals with biliary tract cancer.

Spring Holter, Ayelet Borgida, Felix E.G. Beaudry, Anna Dodd et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2025 conference-abstractOpenAlex

The immunogenomic landscape of primary and metastatic gastroesophageal adenocarcinoma.

Xin Wang, David Chen, Yvonne Bach, Gavin W. Wilson et autres

0 citationsJournal of Clinical Oncology

2025 conference-abstractOpenAlex

Comparison of long-term outcomes for neoadjuvant chemoradiation (NA-CRT) followed by surgery versus (V) definitive chemoradiation (D-CRT) in localized gastroesophageal cancer (GEC): A single-center analysis.

Ronan Andrew McLaughlin, Divya Sharma, Yvonne Bach, Abdul Rehman Farooq et autres

0 citationsJournal of Clinical Oncology

2025 conference-abstractOpenAlex

Beyond Khorana score 2: Molecular correlates of venous thromboembolism in pancreatic cancer.

Jonathon Gerstein, Michelle Chan‐Seng‐Yue, Grainne O ́Kane, Gun Ho Jang et autres

1 citationJournal of Clinical Oncology

2024 conference-abstractOpenAlex

Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01.

Jennifer J. Knox, Elizabeth M. Jaffee, Grainne M. O’Kane, Daniel A. King et autres

23 citationsJournal of Clinical Oncology

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.